Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical & Experimental Metastasis
Published in: Clinical & Experimental Metastasis 6/1999

01-10-1999

Phosphodiesterase type III inhibitor, cilostazol, inhibits colon cancer cell motility

Authors: Kohei Murata, Masao Kameyama, Fumiyo Fukui, Hiroaki Ohigashi, Masahiro Hiratsuka, Yo Sasaki, Toshiyuki Kabuto, Mutsuko Mukai, Tadanori Mammoto, Hitoshi Akedo, Osamu Ishikawa, Shingi Imaoka

Published in: Clinical & Experimental Metastasis | Issue 6/1999

Login to get access
Metadata
Title
Phosphodiesterase type III inhibitor, cilostazol, inhibits colon cancer cell motility
Authors
Kohei Murata
Masao Kameyama
Fumiyo Fukui
Hiroaki Ohigashi
Masahiro Hiratsuka
Yo Sasaki
Toshiyuki Kabuto
Mutsuko Mukai
Tadanori Mammoto
Hitoshi Akedo
Osamu Ishikawa
Shingi Imaoka
Publication date
01-10-1999
Publisher
Kluwer Academic Publishers
Published in
Clinical & Experimental Metastasis / Issue 6/1999
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1023/A:1006626529536

Other articles of this Issue 6/1999

Clinical & Experimental Metastasis 6/1999 Go to the issue

OriginalPaper

A nude mouse model of human osteosarcoma lung metastases for evaluating new therapeutic strategies

OriginalPaper

Co-inoculation of human and murine carcinoma cells induces reciprocal suppression of metastasis by both cell lines

OriginalPaper

Carcinoembryonic antigen facilitates experimental metastasis through a mechanism that does not involve adhesion to liver cells

OriginalPaper

Hepatocyte growth factor promotes migration of human hepatocellular carcinoma via phosphatidylinositol 3-kinase

OriginalPaper

Minimal liver resection strongly stimulates the growth of human colon cancer in the liver of nude mice

OriginalPaper

Expression and activation of pro-gelatinase A by human melanoma cell lines with different tumorigenic potential
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits